Jennifer Lynn Kraschnewski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jennifer Lynn Kraschnewski has a total of 217 co-authors. Here are the top co-authors by number of shared publications:
- Erica Francis
Penn State Health, College of Medicine, Penn State University, Hershey, PA, United States
11 shared publications - Erik Lehman
Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, United States
7 shared publications - Alicia Marie Hoke
Penn State College of Medicine
6 shared publications - Jennifer Mary Poger
Penn State Health, College of Medicine, Penn State University, Hershey, PA, United States
5 shared publications Lan Kong
Department of Public Health Sciences, Penn State College of Medicine, Hershey, United States of America
5 shared publicationsWilliam A. Calo
Department of Public Health Sciences, Penn State College of Medicine, Hershey, United States of America
5 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Springer Nature in Biomedical Engineering Education
- p. 1-14
From Bench to Business: Building Coachable Innovators Through the Innovation Fellows Program
Purpose: Designed to accelerate delivery of translational technologies, The Innovation Fellows (IF) Program at the Center for Medical Innovation blends experiential learning, competency-building, and industry engagement to prepare early-career engineers, clinicians, and scientists for diverse professional pathways, including entrepreneurship, industry, and clinical translation. Fellows consist of senior graduate students, postdoctoral researchers, and medical trainees engaged in translational engineering and health science research. Methods: Anchored in the NSF I-Corps™ framework, this year-long program enhances traditional academic training with structured commercialization experience and a distinctive three-tier mentoring model: an internal subject matter expert, an internal innovation mentor, and an external industry mentor. This triad mentoring approach supports fellows in translating research into market-ready solutions, while fostering critical professional competencies such as interdisciplinary collaboration, stakeholder communication, and coachability. Fellows engage in customer discovery interviews, regulatory pathway analysis, and iterative project refinement, guided by mentors drawn from both academic and industry sectors. A flipped-classroom structure and discovery-driven curriculum position fellows to explore alternative career pathways while staying in academia. Fellows complete pre- and post-program assessments and reflection protocols to evaluate growth in areas such as networking, intellectual property, and strategic planning. Results: Early data from two cohorts show significant gains in commercialization confidence and cross-sector communication skills. Conclusions: This paper presents the structure and early outcomes of the IF Program as a replicable model for integrating workforce-aligned mentoring and industry partnerships into early career biomedical engineering education, while broadening trainees’ professional horizons and accelerating the impact of biomedical innovation.
- 29 July 2026
- Published by Springer Nature in Biomedical Engineering Education
- p. 1-14
Open AccessFrom Bench to Business: Building Coachable Innovators Through the Innovation Fellows Program
Purpose: Designed to accelerate delivery of translational technologies, The Innovation Fellows (IF) Program at the Center for Medical Innovation blends experiential learning, competency-building, and industry engagement to prepare early-career engineers, clinicians, and scientists for diverse professional pathways, including entrepreneurship, industry, and clinical translation. Fellows consist of senior graduate students, postdoctoral researchers, and medical trainees engaged in translational engineering and health science research. Methods: Anchored in the NSF I-Corps™ framework, this year-long program enhances traditional academic training with structured commercialization experience and a distinctive three-tier mentoring model: an internal subject matter expert, an internal innovation mentor, and an external industry mentor. This triad mentoring approach supports fellows in translating research into market-ready solutions, while fostering critical professional competencies such as interdisciplinary collaboration, stakeholder communication, and coachability. Fellows engage in customer discovery interviews, regulatory pathway analysis, and iterative project refinement, guided by mentors drawn from both academic and industry sectors. A flipped-classroom structure and discovery-driven curriculum position fellows to explore alternative career pathways while staying in academia. Fellows complete pre- and post-program assessments and reflection protocols to evaluate growth in areas such as networking, intellectual property, and strategic planning. Results: Early data from two cohorts show significant gains in commercialization confidence and cross-sector communication skills. Conclusions: This paper presents the structure and early outcomes of the IF Program as a replicable model for integrating workforce-aligned mentoring and industry partnerships into early career biomedical engineering education, while broadening trainees’ professional horizons and accelerating the impact of biomedical innovation.
- Open Access
- 21 July 2026
- Published by MDPI AG in Preprints.org
AI-Enabled Digital Twins in Healthcare: Epistemic Foundations, Principles, Progress, and Future Directions
Digital twins have rapidly entered healthcare discourse, accompanied by ambitious claims regarding personalization, prediction, and decision support. Originating in engineering domains characterized by well-observed, controllable, and mechanistically understood systems, the concept is increasingly being applied to biological, clinical, and organizational settings whose underlying assumptions differ substantially. As a result, the term now encompasses a heterogeneous collection of models, simulations, and artificial intelligence (AI) systems, often without clear specification of what is being represented, what can be inferred, or what actions can legitimately be justified.This review develops a scale-aware framework for evaluating healthcare digital twins. Through a structured analysis spanning cardiovascular disease, diabetes, Alzheimer's disease, maternal–fetal health, addiction, radiology, and hospital operations, we argue that the scientific validity and practical utility of a digital twin depend fundamentally on scale. As applications move from mechanistic physiological systems to individual patients, coupled human systems, sociotechnical settings, and healthcare organizations, the central challenges shift from model fidelity and state estimation to non-identifiability, behavioral adaptation, contested objectives, and governance.Across domains, recurring failure modes arise less from insufficient computational capability than from misalignment among state definitions, uncertainty representation, causal support, decision authority, and governance. We examine the roles of AI in state estimation, prediction, uncertainty quantification, and decision support while highlighting its limits in addressing poorly defined state spaces, non-identifiability, causal ambiguity, and normative questions regarding acceptable actions. We further argue that governance is not an external constraint but a foundational component of healthcare digital twins, shaping accountability, lifecycle oversight, data stewardship, and the legitimacy of decisions informed by digital twin outputs.This review reframes healthcare digital twins not as a single technology but as a family of computational representations whose validity depends on scale, context, purpose, and governance. Future progress will depend less on increasingly sophisticated models than on maintaining alignment among representation, evidence, intervention, and accountability, and on ensuring digital twin ambitions remain commensurate with the epistemic conditions and institutional constraints of the systems they seek to represent. Building on this analysis, the review offers complementary research roadmaps for AI and governance that emphasize explicit state semantics, uncertainty-aware inference, decision-centered evaluation, adaptive oversight, and governance-by-design.
- 21 July 2026
- Published by MDPI AG in Preprints.org
Open AccessAI-Enabled Digital Twins in Healthcare: Epistemic Foundations, Principles, Progress, and Future Directions
Digital twins have rapidly entered healthcare discourse, accompanied by ambitious claims regarding personalization, prediction, and decision support. Originating in engineering domains characterized by well-observed, controllable, and mechanistically understood systems, the concept is increasingly being applied to biological, clinical, and organizational settings whose underlying assumptions differ substantially. As a result, the term now encompasses a heterogeneous collection of models, simulations, and artificial intelligence (AI) systems, often without clear specification of what is being represented, what can be inferred, or what actions can legitimately be justified.This review develops a scale-aware framework for evaluating healthcare digital twins. Through a structured analysis spanning cardiovascular disease, diabetes, Alzheimer's disease, maternal–fetal health, addiction, radiology, and hospital operations, we argue that the scientific validity and practical utility of a digital twin depend fundamentally on scale. As applications move from mechanistic physiological systems to individual patients, coupled human systems, sociotechnical settings, and healthcare organizations, the central challenges shift from model fidelity and state estimation to non-identifiability, behavioral adaptation, contested objectives, and governance.Across domains, recurring failure modes arise less from insufficient computational capability than from misalignment among state definitions, uncertainty representation, causal support, decision authority, and governance. We examine the roles of AI in state estimation, prediction, uncertainty quantification, and decision support while highlighting its limits in addressing poorly defined state spaces, non-identifiability, causal ambiguity, and normative questions regarding acceptable actions. We further argue that governance is not an external constraint but a foundational component of healthcare digital twins, shaping accountability, lifecycle oversight, data stewardship, and the legitimacy of decisions informed by digital twin outputs.This review reframes healthcare digital twins not as a single technology but as a family of computational representations whose validity depends on scale, context, purpose, and governance. Future progress will depend less on increasingly sophisticated models than on maintaining alignment among representation, evidence, intervention, and accountability, and on ensuring digital twin ambitions remain commensurate with the epistemic conditions and institutional constraints of the systems they seek to represent. Building on this analysis, the review offers complementary research roadmaps for AI and governance that emphasize explicit state semantics, uncertainty-aware inference, decision-centered evaluation, adaptive oversight, and governance-by-design.
- Open Access
- 25 June 2026
- Published by Association for Computing Machinery (ACM)
- p. 3274-3301
Dr. GPT Will See You Now, but Should It? Exploring the Benefits and Harms of Large Language Models for Health Advice using Crowdsourced Clinical Cases
- 25 June 2026
- Published by Association for Computing Machinery (ACM)
- p. 3274-3301
Open AccessDr. GPT Will See You Now, but Should It? Exploring the Benefits and Harms of Large Language Models for Health Advice using Crowdsourced Clinical Cases
- Open Access
- 19 May 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11
Training healthcare providers in adolescent alcohol and substance use screening through project ECHO in rural Pennsylvania: A brief case report
- 19 May 2026
- Published by Elsevier in Public Health in Practice
- Vol. 11
Open AccessTraining healthcare providers in adolescent alcohol and substance use screening through project ECHO in rural Pennsylvania: A brief case report
- Open Access
- 25 February 2026
- Published by SAGE Publications in Journal of Patient Experience
- Vol. 13
“Moments of Clarity”: A Qualitative Study to Understand Factors Protecting Patients in Active Drug Rehab from Deaths of Despair
Over the past three decades, US mortality rates resulting from suicide, drug overdose, and alcohol-related liver disease—collectively referred to as Deaths of Despair (DoD)—have risen sharply. While epidemiologic patterns are well documented, less is known about the lived experiences of those vulnerable to DoD and the factors that support recovery. This study partnered with an addiction recovery center in a central Pennsylvania community disproportionately affected by despair-related conditions. Seventeen individuals in active recovery participated in in-depth interviews to explore pathways leading to despair and addiction, and sources of resilience. Thematic analysis using MAXQDA software identified three primary themes with subthemes: barriers to recovery (grief from personal loss, isolation, and ineffective coping with pain), shifts from despair (ie, “moments of clarity”) (change in motivation, remorse, and embarrassment), and recovery support (higher power and family, community and healthcare support). These findings provide qualitative insight into the biopsychosocial dynamics of despair and recovery and highlight the importance of grief support, coordinated pain management, emotional reflection, and social and spiritual resources. Such insights may inform clinical practice, community programs, and policy interventions aimed at reducing DoD and supporting long-term recovery.
- 25 February 2026
- Published by SAGE Publications in Journal of Patient Experience
- Vol. 13
Open Access“Moments of Clarity”: A Qualitative Study to Understand Factors Protecting Patients in Active Drug Rehab from Deaths of Despair
Over the past three decades, US mortality rates resulting from suicide, drug overdose, and alcohol-related liver disease—collectively referred to as Deaths of Despair (DoD)—have risen sharply. While epidemiologic patterns are well documented, less is known about the lived experiences of those vulnerable to DoD and the factors that support recovery. This study partnered with an addiction recovery center in a central Pennsylvania community disproportionately affected by despair-related conditions. Seventeen individuals in active recovery participated in in-depth interviews to explore pathways leading to despair and addiction, and sources of resilience. Thematic analysis using MAXQDA software identified three primary themes with subthemes: barriers to recovery (grief from personal loss, isolation, and ineffective coping with pain), shifts from despair (ie, “moments of clarity”) (change in motivation, remorse, and embarrassment), and recovery support (higher power and family, community and healthcare support). These findings provide qualitative insight into the biopsychosocial dynamics of despair and recovery and highlight the importance of grief support, coordinated pain management, emotional reflection, and social and spiritual resources. Such insights may inform clinical practice, community programs, and policy interventions aimed at reducing DoD and supporting long-term recovery.
- 22 July 2025
- Published by Edward Elgar Publishing
- p. 167-180
Leveraging community health workers to support research studies with diverse populations
- 22 July 2025
- Published by Edward Elgar Publishing
- p. 167-180
Leveraging community health workers to support research studies with diverse populations
- Open Access
- 9 June 2025
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 9 (1) , e140
Pilot wrap-around support initiative: Enhanced support for internally funded CTSA pilot awards
The Penn State Clinical and Translational Science Institute (CTSI) Pilot Wrap-Around Support Initiative, implemented in the 2023 pilot funding cycle, was designed to help research teams access comprehensive research support for their pilot projects throughout the entire funding cycle. The overall goal of the initiative is to support researchers to improve timely and successful completion of project aims with a high likelihood of receiving follow-on external funding to advance clinical and translational science. This initiative builds upon existing CTSI resources by adding new support mechanisms, including Core consultations during application development, a pilot project Principal Investigator (PI) orientation meeting, and team science collaboration planning for funded teams. In the 2023 and 2024 funding cycles, we received 55 letters of intent and 23 invited full applications. Pilot project PIs engaged in each of our new and existing support mechanisms to various degrees, resulting in six funded projects that started July 1, 2024 and four funded projects set to begin July 1, 2025. Plans for the initiative include supporting access to clinical research staff through a CTSI staffing program and overarching pilot project evaluation to guide future programmatic improvement.
- 9 June 2025
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 9 (1) , e140
Open AccessPilot wrap-around support initiative: Enhanced support for internally funded CTSA pilot awards
The Penn State Clinical and Translational Science Institute (CTSI) Pilot Wrap-Around Support Initiative, implemented in the 2023 pilot funding cycle, was designed to help research teams access comprehensive research support for their pilot projects throughout the entire funding cycle. The overall goal of the initiative is to support researchers to improve timely and successful completion of project aims with a high likelihood of receiving follow-on external funding to advance clinical and translational science. This initiative builds upon existing CTSI resources by adding new support mechanisms, including Core consultations during application development, a pilot project Principal Investigator (PI) orientation meeting, and team science collaboration planning for funded teams. In the 2023 and 2024 funding cycles, we received 55 letters of intent and 23 invited full applications. Pilot project PIs engaged in each of our new and existing support mechanisms to various degrees, resulting in six funded projects that started July 1, 2024 and four funded projects set to begin July 1, 2025. Plans for the initiative include supporting access to clinical research staff through a CTSI staffing program and overarching pilot project evaluation to guide future programmatic improvement.
- Open Access
- 6 June 2025
- Published by Elsevier in AJPM Focus
- Vol. 4 (5) , 100378
Prediabetes Awareness Barriers and Enablers: National Health and Nutrition Examination Survey 2011–2020
- 6 June 2025
- Published by Elsevier in AJPM Focus
- Vol. 4 (5) , 100378
Open AccessPrediabetes Awareness Barriers and Enablers: National Health and Nutrition Examination Survey 2011–2020
- Open Access
- 6 March 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e59913
Using the Community Resilience Model and Project ECHO to Build Resiliency in Direct Support Professionals: Protocol for a Longitudinal Survey
Background: Individuals with intellectual disabilities or autism spectrum disorder (ID/A) sometimes require supportive services from direct support professionals (DSPs). The supportive care provided to individuals with ID/A by DSPs can vary from assistance with daily living activities to navigating society. The COVID-19 pandemic not only exacerbated poor outcomes for individuals with ID/A but also for DSPs, who report experiencing burnout in the aftermath of the pandemic. DSPs are critical to providing much-needed support to individuals with ID/A. Objective: The goal of this study is to evaluate the impact of the community resilience model on DSP burnout and neurodivergent client outcomes using the Project ECHO (Extension for Community Healthcare Outcomes) telementoring platform as a dissemination tool. Methods: This protocol leverages community resilience theory and telementoring through the Project ECHO model to foster resilience in DSPs and their neurodiverse client population. ECHO participants’ resilience behaviors will be evaluated via surveys including the Connor Davison Resilience Scale and the WHO-5 Well-Being Index. These surveys will be administered preprogram, at the end of the 8-week ECHO program, and 90 days after the ECHO program’s completion. Pre-post relationships will be assessed using generalized estimating equations. The main outcomes will be self-reported changes in knowledge, self-efficacy, and resilience. Results: All ECHO program cohorts and follow-up data collection have concluded, with 131 survey participants. The project team is currently analyzing and interpreting the data. We anticipate having all data analyzed and interpreted by February 2025. Conclusions: DSPs provide critical services to individuals with ID/A. By providing skills in resiliency via the ECHO model, participants will be able to apply resiliency to their own professional lives while fostering resilience within their neurodiverse client base, leading to increased positive outcomes for both groups. International Registered Report Identifier (IRRID): DERR1-10.2196/59913
- 6 March 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e59913
Open AccessUsing the Community Resilience Model and Project ECHO to Build Resiliency in Direct Support Professionals: Protocol for a Longitudinal Survey
Background: Individuals with intellectual disabilities or autism spectrum disorder (ID/A) sometimes require supportive services from direct support professionals (DSPs). The supportive care provided to individuals with ID/A by DSPs can vary from assistance with daily living activities to navigating society. The COVID-19 pandemic not only exacerbated poor outcomes for individuals with ID/A but also for DSPs, who report experiencing burnout in the aftermath of the pandemic. DSPs are critical to providing much-needed support to individuals with ID/A. Objective: The goal of this study is to evaluate the impact of the community resilience model on DSP burnout and neurodivergent client outcomes using the Project ECHO (Extension for Community Healthcare Outcomes) telementoring platform as a dissemination tool. Methods: This protocol leverages community resilience theory and telementoring through the Project ECHO model to foster resilience in DSPs and their neurodiverse client population. ECHO participants’ resilience behaviors will be evaluated via surveys including the Connor Davison Resilience Scale and the WHO-5 Well-Being Index. These surveys will be administered preprogram, at the end of the 8-week ECHO program, and 90 days after the ECHO program’s completion. Pre-post relationships will be assessed using generalized estimating equations. The main outcomes will be self-reported changes in knowledge, self-efficacy, and resilience. Results: All ECHO program cohorts and follow-up data collection have concluded, with 131 survey participants. The project team is currently analyzing and interpreting the data. We anticipate having all data analyzed and interpreted by February 2025. Conclusions: DSPs provide critical services to individuals with ID/A. By providing skills in resiliency via the ECHO model, participants will be able to apply resiliency to their own professional lives while fostering resilience within their neurodiverse client base, leading to increased positive outcomes for both groups. International Registered Report Identifier (IRRID): DERR1-10.2196/59913
- Open Access
- 17 August 2024
- Published by Springer Nature in BMC Health Services Research
- Vol. 24 (1) , 1-7
Implementation of COVID-19 infection control best practices in nursing homes amid the pandemic
The COVID-19 pandemic has claimed around 170,000 lives among nursing home residents and staff in the United States through April 2023. In a cluster randomized controlled trial (RCT) with 136 nursing homes, we delivered training to improve COVID-19 infection control best practices. We sought to assess the implementation of infection control practices in participating nursing homes. Concurrent with the delivery of the RCT (January-November 2021), we surveyed nursing home administrators (NHAs, n = 38) at baseline and 6-month follow-up. Using validated items from the Centers for Disease Control and Prevention (CDC), the surveys inquired about 80 infection control best-practice activities (yes/no). The survey also asked seven scales corresponding to inner setting factors that may have impacted implementation. We assessed changes in infection control practices and inner setting factors between baseline and 6-month follow-up. Overall, the implementation of 11 best practices changed over time. NHAs reported an increase in the availability of informational materials for residents and families (84% vs. 100%, p = 0.031), the use of alcohol-based hand sanitizer over soap (76% vs. 97%, p = 0.008), and the development of contingency plans for increased postmortem care (53% vs. 82%, p = 0.013). The implementation of four best-practice visitation policies and three communal restrictions decreased between baseline and 6-month follow-up (all p < 0.05). Regarding inner setting factors, only culture stress (perceived strain, stress, and role overload) increased between surveys (mean scores: 3.14 vs. 3.58, p = 0.004). This study was among the first to report changes in implementing COVID-19 infection control best practices in nursing homes amid the pandemic. Culture stress was an important inner setting factor that may have impacted implementation activities. NCT04499391 August 3rd, 2020
- 17 August 2024
- Published by Springer Nature in BMC Health Services Research
- Vol. 24 (1) , 1-7
Open AccessImplementation of COVID-19 infection control best practices in nursing homes amid the pandemic
The COVID-19 pandemic has claimed around 170,000 lives among nursing home residents and staff in the United States through April 2023. In a cluster randomized controlled trial (RCT) with 136 nursing homes, we delivered training to improve COVID-19 infection control best practices. We sought to assess the implementation of infection control practices in participating nursing homes. Concurrent with the delivery of the RCT (January-November 2021), we surveyed nursing home administrators (NHAs, n = 38) at baseline and 6-month follow-up. Using validated items from the Centers for Disease Control and Prevention (CDC), the surveys inquired about 80 infection control best-practice activities (yes/no). The survey also asked seven scales corresponding to inner setting factors that may have impacted implementation. We assessed changes in infection control practices and inner setting factors between baseline and 6-month follow-up. Overall, the implementation of 11 best practices changed over time. NHAs reported an increase in the availability of informational materials for residents and families (84% vs. 100%, p = 0.031), the use of alcohol-based hand sanitizer over soap (76% vs. 97%, p = 0.008), and the development of contingency plans for increased postmortem care (53% vs. 82%, p = 0.013). The implementation of four best-practice visitation policies and three communal restrictions decreased between baseline and 6-month follow-up (all p < 0.05). Regarding inner setting factors, only culture stress (perceived strain, stress, and role overload) increased between surveys (mean scores: 3.14 vs. 3.58, p = 0.004). This study was among the first to report changes in implementing COVID-19 infection control best practices in nursing homes amid the pandemic. Culture stress was an important inner setting factor that may have impacted implementation activities. NCT04499391 August 3rd, 2020